learn Rapamycin mTOR regulator and immunosuppressant used more recently for anti-aging and hair regrowth
research Efficacy and Safety of Sirolimus for Blue Rubber Bleb Nevus Syndrome: A Prospective Study 13 citations , January 2021 in “The American journal of gastroenterology” Sirolimus effectively reduces lesions and improves quality of life in Blue Rubber Bleb Nevus Syndrome with manageable side effects.
research Acne keloidalis nuchae in renal transplant patients receiving tacrolimus and sirolimus 6 citations , April 2016 in “Australasian journal of dermatology” Renal transplant patients on tacrolimus and sirolimus may develop acne keloidalis nuchae.
research Long-Term Effects of Sirolimus on Human Skin TSC2-Null Fibroblast‒Like Cells 1 citations , March 2021 in “Journal of Investigative Dermatology” Sirolimus can reduce tumor cell size in TSC-related skin tumors, but continuous treatment is needed to maintain benefits.
research Mammalian target of rapamycin complex 1 (mTORC1) may modulate the timing of anagen entry in mouse hair follicles 28 citations , November 2012 in “Experimental dermatology” A protein complex called mTORC1 likely affects when hair growth starts in mice.
research Effects of immunosuppressive peptidyl-prolyl cis-trans isomerase (PPIase) inhibitors, cyclosporin A, FK506, ascomycin and rapamycin, on hair growth initiation in mouse: immunosuppression is not required for new hair growth 20 citations , January 1995 in “Journal of Dermatological Science” Cyclosporin A and FK506 can start new hair growth without needing immunosuppression.